MICHELE YORK to Amyotrophic Lateral Sclerosis
This is a "connection" page, showing publications MICHELE YORK has written about Amyotrophic Lateral Sclerosis.
Connection Strength
0.805
-
Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22.
Score: 0.279
-
A Guide to Understanding the Benefits of a Multidisciplinary Team Approach to Amyotrophic Lateral Sclerosis (ALS) Treatment. Arch Phys Med Rehabil. 2019 03; 100(3):583-586.
Score: 0.124
-
Pseudobulbar Affect Correlates With Mood Symptoms in Parkinsonian Disorders but Not Amyotrophic Lateral Sclerosis. J Neuropsychiatry Clin Neurosci. 2018; 30(3):214-219.
Score: 0.121
-
Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24.
Score: 0.072
-
A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8.
Score: 0.070
-
Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 03; 11(3):303-11.
Score: 0.070
-
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010 May; 17(5):733-9.
Score: 0.069